China NMPA Drug Inspection - Shanghai Laiting Clinic - Bupleurum
China NMPA drug inspection for Shanghai Laiting Clinic published March 13, 2018. Drug: Bupleurum. The Shanghai Municipal Food and Drug Administration (SMFDA) released its 2018 Issue 2 Drug Supervision and Sampling Qual
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanghai Laiting Clinic published March 13, 2018. Drug: Bupleurum. The Shanghai Municipal Food and Drug Administration (SMFDA) released its 2018 Issue 2 Drug Supervision and Sampling Qual
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Shanghai Laiting ClinicInspection Date
Unknown Date
Product Type
ID: 2064ad6a-984c-4248-aded-ab16b2aefb43
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox